Penetration of topical, oral, and combined administered ofloxacin into the subretinal fluid

British Journal of Ophthalmology

Volumn 83, Issue 10, 1999, Pages 1183-1185

  Çekiç, Osman ^a,c   Batman, Cosar ^a   Yasar, Ümit ^b   Totan, Yüksel ^a   Basci, Nursabah E ^b   Bozkurt, Atilla ^b   Zilelioglu, Orhan ^a   Kayaalp, S Oguz ^b  

^a SSK Ankara Eye Hospital   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

OFLOXACIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BIOAVAILABILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG PENETRATION; DRUG TISSUE LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA DETACHMENT; SUBRETINAL FLUID; TOPICAL DRUG ADMINISTRATION;

EID: 0032870478     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.83.10.1183     Document Type: Article

References (23)

1. Drew RH, Gallis HA. Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application. Pharmacotherapy 1988;8:35-46.
2. Just PM. Overview of the fluoroquinolone antibiotics. Pharmacotherapy 1993;13(suppl 2):4-47.
3. The Ofloxacin Study Group. Ofloxacin monotherapy for the primary treatment of microbial keratitis. A double-masked, randomized, controlled trial with conventional dual therapy. Ophthalmology 1997;104:1902-9.
4. Gwon A, the Ofloxacin Study Group. Topical ofloxacin compared with gentamicin in the treatment of external ocular infection. Br J Ophthalmol 1992;76:714-8.
5. Akkan AG, Mutlu I, Özyazgan S, et al. Comparative tear concentrations of topically applied ciprofloxacin, ofloxacin, and norfloxacin in human eyes. Int J Clin Pharmacol Ther 1997;35:214-7.
6. Diamond JP, White L, Leeming JP, et al. Topical 0.3% ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: a new method for comparative evaluation of ocular drug penetration. Br J Ophthalmol 1995;79:606-9.
7. Durmaz B, Marol S, Durmaz R, et al. Aqueous humor penetration of topically applied ciprofloxacin, ofloxacin and tobramycin. Arzneimittelforschung 1997;47:413-5.
8. Akkan AG, Mutlu I, Özyazgan S, et al. Penetration of topically applied ciprofloxacin, norfloxacin and ofloxacin into the aqueous humor of the uninflamed human eye. J Chemother 1997;9:257-62.
9. Çekiç O, Batman C, Totan Y, et al. Penetration of ofloxacin and ciprofloxacin in aqueous humor after topical administration. Ophthalmic Surg Lasers 1999;30:465-8.
10. Hanioglu-Kargi S, Basci N, Soysal H, et al. The penetration of ofloxacin into human aqueous humor given by various routes. Eur J Ophthalmol 1998;8:33-6.
11. Verbraeken H, Verstraete A, Van de Velde E, et al. Penetration of gentamicin and ofloxacin in human vitreous after systemic administration. Graefes Arch Clin Exp Ophthalmol (suppl) 1996;234:59-65.
12. Donnenfeld ED, Perry HD, Synder RW, et al. Intracorneal, aqueous humor, and vitreous humor penetration of topical and oral ofloxacin. Arch Ophthalmol 1997;115:173-6.
13. Çekiç O, Batman C, Yasar Ü, et al. Penetration of ofloxacin in human aqueous and vitreous humors following oral and topical administration. Retina 1998;18:521-5.
14. Basci NE, Hanioglu-Kargi S, Soysal H, et al. Determination of ofloxacin in human aqueous humor by high-performance liquid chromotography with fluorescence detection. J Pharm Biomed Anal 1997;15:663-6.
15. Lesk MR, Ammann H, Marcil G, et al. The penetration of oral ciprofloxacin into the aqueous humor, vitreous, and subretinal fluid of humans. Am J Ophthalmol 1993;115:623-8.
16. Richman J, Zolezio H, Tang-Liu D. Comparison of ofloxacin, gentamicin, and tobramycin concentrations in tears and in vitro MICs for 90% of test organisms. Antimicrob Agents Chemother 1990;34:1602-4.
17. Behrens-Baumann W. Absorption of topically administered ciprofloxacin, ofloxacin and gentamicin in the inflammed rabbit eye. Ophthalmologica 1996;210:119-22.
18. Gatti G, Panozzo G. Effect of inflammation on intraocular penetration of intravenous ofloxacin in albino rats. Antimicrob Agents Chemother 1995;39:549-52.
19. Cunha-Vaz J, Debreu JRF, Campos AJ, et al. Early breakdown of the blood-retinal barrier in diabetes. Br J Ophthalmol 1975;59:649-56.
20. Seal DV, Bron AJ. Infections of the eye. In: Q'Grady F, Lambert HP, Finch RG, Greenwood D, eds. Antibiotic and chemotherapy. 7th ed. Edinburgh: Churchill Livingstone, 1997:788.
21. David DB, Kirkby GR, Noble BA. Bacillus cereus endophthalmitis. Br J Ophthalmol 1994;78:577-80.
22. Alfaro DV, Davis J, Kim S, et al. Experimental Bacillus cereus post-traumatic endophthalmitis and treatment with ciprofloxacin. Br J Ophthalmol 1996;80:755-8.
23. Todd PA, Faulds D. Ofloxacin: a reappraisal of its antimicrobial activity, pharmacology and therapeutic use. Drugs 1991;42:825-76.